Gastroesophageal reflux disease and helicobacter pylori infection

Reviews in Gastroenterological Disorders

Volumn 3, Issue 1, 2003, Pages 1-7

  Vakil, Nimish ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Duodenal ulcer; Gastric; Gastroesophageal reflux disease; Helicobacter pylori

Indexed keywords

AMOXICILLIN; BISMUTH; CAGA PROTEIN; CLARITHROMYCIN; ESOMEPRAZOLE; GASTRIN; GASTRIN RELEASING PEPTIDE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; TETRACYCLINE; TINIDAZOLE;

ADENOCARCINOMA; ATROPHY; CLINICAL TRIAL; DEVELOPED COUNTRY; DRUG EFFICACY; DUODENUM ULCER; ERADICATION THERAPY; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INTESTINE METAPLASIA; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; REFLUX ESOPHAGITIS; RELAPSE; REVIEW; STOMACH ACID SECRETION; STOMACH DISEASE; STOMACH PH;

ADULT; ESOPHAGITIS; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; PROTON PUMPS; RECURRENCE;

EID: 0037412399     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Dixon MF. Patterns of inflammation linked to ulcer disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(1):27-40.
2. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut. 1993;34:888-892.
3. el-Omar EM, Penman ID, Ardill JE, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995;109:681-691.
4. Gutierrez O, Melo M, Segura AM, et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol. 1997;32:664-668.
5. Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24 hour pH monitoring. Gut. 1999;13:155-162.
6. El-Serag HB, Sonnenberg A, Jamal MM, et al. Corpus gastritis is protective against reflux esophagitis. Gut. 1999;45:181-185.
7. Manes G, Mosca S, Laccetti M, et al. Helicobacter pylori infection, patterns of gastritis and symptoms in erosive and non-erosive reflux disease. Scand J Gastroenterol. 1999;34:658-662.
8. Wu JCY, Sung JJY, Chan FKL, et al. Helicobacter pylori infection is associated with milder gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2000;14:427-432.
9. Voutilainen M, Sipponen P, Mecklin JP, et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion. 2000;61:6-13.
10. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux esophagitis and Barrett's esophagus. Gut. 1997;40:9-13.
11. Hackelsberger A, Schultze V, Gunther T, et al. The prevalence of Helicobacter pylori gastritis in patients with reflux esophagitis: a case-control study. Eur J Gastroenterol Hepatol. 1998;10:465-468.
12. Csendes A, Smok G, Cerda G, et al. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus. 1997;10:38-42.
13. Yamaji Y, Mitsushima T, Ikuma H, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux esophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335-340.
14. Gisbert J, De-Pedro C, Barreiro A, et al. H. pylori and gastro-esophageal reflux disease: lack of influence of infection on pH-metric and endoscopic findings. Gastroenterology. 1999;116:A172.
15. Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol. 2000;95:387-394.
16. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50-57.
17. Warburton-Timms VJ, Charlett A, Valori RM, et al. The significance of cagA(+) Helicobacter pylori in reflux esophagitis. Gut. 2001;49:341-346.
18. Tefera S, Hatlebakk JG, Berstad A. The effect of Helicobacter pylori eradication on gastroesophageal reflux. Aliment Pharmacol Ther. 1999;13:915-920.
19. Manifold DK, Anggiansah A, Rowe I, et al. Gastro-esophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritis. Eur J Gastroenterol Hepatol. 2001;13:535-539.
20. Wu JC, Chan FK, Wong SK, et al. Effect of helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Aliment Pharmacol Ther. 2002;16:545-552.
21. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997;112:1442-1447.
22. Hamada H, Haruma K, Mihara M, et al. High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729-735.
23. Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-esophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther. 2000;14:45-51.
24. Fallone C, Barkun A, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol. 2000;95:914-920.
25. Schwizer W, Thurmshirn M, Dent J, et al. Helicobacter pylori and symptomatic relapse of gastro-esophageal reflux disease: a randomized controlled trial. Lancet. 2001;357:1738-1742.
26. Moayyedi P, Bardhan C, Young L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology. 2001;121:1120-1126.
27. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology. 1996;110:728-732.
28. Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology. 1999;117:11-16.
29. Carlsson R, Bate C, Dent J, et al. Does H. pylori infection influence the response to treatment with acid inhibition in patients with GERD? Scand J Gastroenterol. 1997;32(suppl 224):F70.
30. Vakil N, Kahrilas P, Magner D, et al. Does baseline H. pylori status impact erosive esophagitis healing rates? [abstract]. Am J Gastroenterol. 2000;95:2438.
31. Vakil N, Zuckerman S, Levine J. H. pylori infection and the severity of esophagitis and healing with lansoprazole and esomeprazole. Gastroenterology. 2002;122:A-199.
32. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol. 1999;94:884-887.
33. Kuipers EJ, Lundell L, Klinkenberg-Knol EG, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018-1022.
34. Lundell L, Miettinen P, Myrvold HB, et al. Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology. 1999;117:319-326.